Cargando…
MeCP2 in the regulation of neural activity: Rett syndrome pathophysiological perspectives
Rett syndrome (RTT), an X-linked neurodevelopment disorder, occurs in approximately one out of 10,000 females. Individuals afflicted by RTT display a constellation of signs and symptoms, affecting nearly every organ system. Most striking are the neurological manifestations, including regression of l...
Autores principales: | Cuddapah, Vishnu Anand, Sinifunanya, Elvee Nwaobi, Percy, Alan K, Olsen, Michelle Lynne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7337177/ https://www.ncbi.nlm.nih.gov/pubmed/32669918 http://dx.doi.org/10.2147/DNND.S61269 |
Ejemplares similares
-
MeCP2 Deficiency Leads to Loss of Glial Kir4.1
por: Kahanovitch, Uri, et al.
Publicado: (2018) -
Glial Dysfunction in MeCP2 Deficiency Models: Implications for Rett Syndrome
por: Kahanovitch, Uri, et al.
Publicado: (2019) -
Structural investigation of Rett-inducing MeCP2 mutations()
por: Spiga, Ottavia, et al.
Publicado: (2018) -
Rett mutations attenuate phase separation of MeCP2
por: Fan, Chunyan, et al.
Publicado: (2020) -
The Molecular Functions of MeCP2 in Rett Syndrome Pathology
por: Sharifi, Osman, et al.
Publicado: (2021)